Gapping up
In reaction to strong earnings/guidance:
- RECN +9.2%
M&A news:
- AMID +29.8% (American Midstream Partners receives revised buyout offer from ArcLight of $4.50 per common unit)
- ZAGG +3.8% (acquires HALO for total purchase price of $43 mln in cash and stock)
Select China related names showing strength:
- WB +3.6%, JD +2.6%, MOMO +2.4%, BABA +2.1%, BIDU +1.9%
Select metals/mining stocks trading higher:
- BBL +3.7%, MT +3.5%, BHP +3.3%, RIO +3.1%, FCX +2.3%
Other news:
- NVAX +11.8% (announces positive Phase 2 NanoFlu results in older adults; sets the stage for Phase 3 clinical trial in 2019)
- CRSP +3.5% (CRISPR Therapeutics and Vertex Pharma (VRTX) announce that the FDA has granted Fast Track Designation for CTX001 for the treatment of sickle cell disease)
- SQ +2.4% (announced that Amrita Ahuja will join the company as CFO)
- BIIB +1.9% (Biogen and C4 Therapeutics enter into strategic collaboration to investigate the use of C4T's novel protein degradation platform to discover and develop potential new treatments for neurological conditions) .
Analyst comments:
- ETSY +4.5% (upgraded to Buy from Neutral at Goldman)
- COTY +2.9% (upgraded to Neutral from Underweight at JP Morgan)
- ARES +2.9% (added to Conviction Buy List at Goldman)
- CELG +2% (upgraded to Neutral at Goldman)
- EXPE +1.8% (upgraded to Buy from Neutral at Goldman)
- GDOT +1.7% (upgraded to Buy at BTIG)